What is the immediate treatment for a patient presenting with Hyperosmolar Hyperglycemic State (HHS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate Treatment for Hyperosmolar Hyperglycemic State (HHS)

The immediate treatment for Hyperosmolar Hyperglycemic State (HHS) must begin with aggressive fluid resuscitation using 0.9% sodium chloride to restore circulating volume, followed by insulin therapy only after initial fluid replacement has begun to take effect. 1

Initial Assessment and Diagnosis

HHS is characterized by:

  • Plasma glucose >600 mg/dL (>30 mmol/L)
  • Serum osmolality ≥320 mOsm/kg
  • Arterial pH >7.3
  • Serum bicarbonate >18 mEq/L
  • Minimal or absent ketones
  • Marked dehydration and neurological symptoms 2, 1

Treatment Algorithm

Phase 1: First Hour (0-60 minutes)

  1. Fluid Resuscitation

    • Begin with 0.9% sodium chloride (normal saline) 1
    • Focus on restoring circulating volume to ensure adequate perfusion of vital organs 3
    • Fluid losses in HHS are typically 100-220 mL/kg - significantly higher than in DKA 1
    • Use caution in elderly patients and those with cardiac or renal disease 1
  2. Laboratory Monitoring

    • Measure or calculate serum osmolality regularly using formula: [(2×Na+) + glucose + urea] 1
    • Monitor electrolytes, particularly potassium
    • Check renal function
    • Assess for precipitating causes (infection most common) 4

Phase 2: Hours 1-6

  1. Continue Fluid Therapy

    • Continue with 0.9% sodium chloride until hemodynamically stable 1, 5
    • Then transition to 0.45% sodium chloride (hypotonic saline) 3
    • Target fluid replacement: average of 9L over 48 hours 4
  2. Insulin Therapy

    • Critical point: Unlike DKA, withhold insulin until blood glucose stops falling with IV fluids alone, unless ketonemia is present 1, 5
    • When started, give initial bolus of 0.15 U/kg IV, followed by continuous infusion at 0.1 U/kg/hour 4
    • Adjust to achieve gradual blood glucose reduction
  3. Potassium Replacement

    • Begin potassium replacement once urine output is established and serum potassium levels are known 2, 4
    • Add 20-40 mEq/L potassium to IV fluids when K+ <5.5 mEq/L 2

Phase 3: Hours 6-24

  1. Glucose Management

    • Add 5% or 10% dextrose when blood glucose falls below 250-300 mg/dL (14 mmol/L) 4, 1
    • Reduce insulin infusion rate but continue to clear any remaining ketones
    • Target blood glucose: 10-15 mmol/L (180-270 mg/dL) in first 24 hours 1
  2. Osmolality Correction

    • Aim for gradual decline in osmolality (3.0-8.0 mOsm/kg/h) 1
    • Too rapid correction increases risk of cerebral edema and central pontine myelinolysis 5

Monitoring During Treatment

  • Vital signs and neurological status every 1-2 hours
  • Blood glucose hourly
  • Electrolytes, venous pH, and osmolality every 2-4 hours 2, 1
  • Fluid input/output

Common Pitfalls and Caveats

  1. Fluid Management Errors

    • Inadequate initial fluid resuscitation
    • Too rapid correction of osmolality (aim for 3-8 mOsm/kg/h) 1, 5
    • Failure to recognize that fluid replacement alone will cause blood glucose to fall 5
  2. Insulin Timing Errors

    • Starting insulin too early before adequate fluid resuscitation can be detrimental 5
    • Unlike DKA, HHS may initially respond to fluid therapy alone without insulin 1
  3. Electrolyte Imbalances

    • Failure to monitor and replace potassium
    • Misinterpreting initial rise in sodium as indication for hypotonic fluids (this is expected) 5
  4. Complications to Monitor

    • Vascular occlusions (mesenteric artery occlusion, myocardial infarction)
    • Disseminated intravascular coagulopathy
    • Rhabdomyolysis
    • Cerebral edema and central pontine myelinolysis 4, 5
  5. Precipitating Causes

    • Failure to identify and treat underlying infections (most common cause) 4
    • Overlooking medication causes (diuretics, corticosteroids, beta-blockers) 3

Resolution Criteria

HHS is considered resolved when:

  • Osmolality <300 mOsm/kg
  • Hypovolemia corrected (urine output ≥0.5 mL/kg/h)
  • Cognitive status returned to pre-morbid state
  • Blood glucose <15 mmol/L (270 mg/dL) 1

References

Guideline

Diabetic Ketoacidosis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hyperosmolar hyperglycemic state.

American family physician, 2005

Research

Management of hyperosmolar hyperglycaemic state in adults with diabetes.

Diabetic medicine : a journal of the British Diabetic Association, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.